Moderna: US Government Received $400 Million in Covid “Vaccine” Royalty Payments

Moderna said on Feb. 23 that it recently reached a patent agreement with the U.S. government over disputed technology that is featured in its COVID-19 vaccine.

In December 2022, Moderna entered “a nonexclusive patent license agreement” with the National Institute of Allergy and Infectious Diseases (NIAID), said CFO Jamey Mock during an earnings call on Thursday.

The agreement lets the company use “certain patent rights concerning stabilizing prefusion coronavirus spike proteins and the resulting stabilized proteins for the use in COVID-19 vaccine products,” Mock said.

We are primarily funded by readers. Please subscribe and donate to support us!

Under the agreement, Moderna sent a “catch-up payment” of $400 million to the NIAID before the new year, according to Moderna executives.

“We have agreed to pay low single-digit royalties on future net sales of our COVID-19 vaccines,” Mock said.

www.theepochtimes.com/us-government-received-400-million-in-covid-19-vaccine-royalty-payments-moderna_5078600.html?utm_source=partner&utm_campaign=TheLibertyDaily

Views:

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.